Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01904448 · ClinicalTrials.gov registry record · NA
Auditory Brainstem Implantation in Young Children
A NA study of Developmental Cochlear Nerve Deficiency and Acquired Cochlear Nerve Deficiency, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01904448 is a NA study of Developmental Cochlear Nerve Deficiency and Acquired Cochlear Nerve Deficiency that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01904448, a NA study of Developmental Cochlear Nerve Deficiency and Acquired Cochlear Nerve Deficiency, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
To purpose of this feasibility study is to demonstrate the safety and efficacy of the Nucleus 24 Multichannel Auditory Brainstem Implant (ABI, Cochlear Corp, Sydney, AUS) in children without the diagnosis of neurofibromatosis type II (NFII) that have either experienced failed cochlear implantation (CI) or have been unable to receive a CI secondary to cochlear or cochlear nerve disorders. These conditions can include: developmental or acquired cochlear nerve deficiency (CND), cochlear aplasia (Michel), post-meningitic cochlear ossification or cochlear malformation. This study proposes to implant up to 10 young children (\<5 yrs. of age) with the Nucleus 24 Multichannel ABI (Sydney, AUS) in an attempt to demonstrate safety of the surgical procedure, tolerance of device stimulation, and the potential for auditory benefit beyond that experienced with their CI. This study will provide the preliminary experience for a larger scale clinical trial. Aim 1: Demonstrate the safety of ABI surgery in children. Aim 2: Demonstrate the development of sound awareness and improved speech understanding among children implanted with the ABI when compared to their baseline skills. Aim 3: Demonstrate the development of oral language skills following the use of the ABI that were not evident prior to its use.
Conditions Studied
Interventions
- DEVICE Auditory Brainstem Implantation in Children
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-09 |
| Est. Completion | 2017-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01904448
The ClinicalTrials.gov registry entry for NCT01904448 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Developmental Cochlear Nerve Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Auditory Brainstem Implantation in Children is the first listed.
NCT01904448 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01904448 about?
NCT01904448 is a clinical study titled "Auditory Brainstem Implantation in Young Children". To purpose of this feasibility study is to demonstrate the safety and efficacy of the Nucleus 24 Multichannel Auditory Brainstem Implant (ABI, Cochlear Corp, Sydney, AUS) in children without the diagnosis of neurofibromatosis type II (NFII) that have either experienced failed cochlear implantation (...
What is the current status of trial NCT01904448?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-09. Estimated completion is 2017-10-01.
What conditions does trial NCT01904448 study?
This clinical trial studies the following conditions: Developmental Cochlear Nerve Deficiency, Acquired Cochlear Nerve Deficiency, Cochlear Aplasia, Post-meningitis Cochlear Ossification, Cochlear Malformation.
What interventions are being tested in trial NCT01904448?
The interventions under investigation include: Auditory Brainstem Implantation in Children (DEVICE).
Who is sponsoring clinical trial NCT01904448?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01904448 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Developmental Cochlear Nerve Deficiency
All registered trials for this condition
Acquired Cochlear Nerve Deficiency
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.